Gutmann L, Kitzis M D, Acar J F
Medical Microbiology Laboratory, Broussais Hospital, Paris, France.
J Int Med Res. 1990;18 Suppl 4:37D-47D.
Resistance to third-generation cephalosporins occurs as a result of either the production of high concentrations of chromosomal cephalosporinase or, increasingly, the presence of broad-spectrum plasmid-mediated beta-lactamases. Both cases represent the response of bacteria in the hospital setting to the selection pressure brought to bear by the use of these antibiotics. Continued evolution of the plasmid-mediated enzymes is occurring as new antibiotics are introduced, probably reflecting the process that began when the first beta-lactamase apparently evolved from the penicillin-binding proteins. beta-Lactamase inhibitors offer one approach to dealing with the evolution of resistance to previously beta-lactamase-stable antibiotics.
对第三代头孢菌素产生耐药性是由于产生高浓度的染色体头孢菌素酶,或者越来越多地是由于存在广谱质粒介导的β-内酰胺酶。这两种情况均代表医院环境中细菌对使用这些抗生素所带来的选择压力的反应。随着新抗生素的引入,质粒介导的酶在持续进化,这可能反映了自首个β-内酰胺酶显然从青霉素结合蛋白进化而来时就开始的过程。β-内酰胺酶抑制剂提供了一种应对先前对β-内酰胺酶稳定的抗生素耐药性演变的方法。